Adeboyeku, D <br/><br/>
Twice vs three-times daily antibiotics in the treatment of pulmonary exacerbations of cystic fibrosis.  [electronic resource] 

 -  Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society  Jan 2011 
 - 25-30 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1873-5010 
<br/><br/><label>Standard No.: </label>10.1016/j.jcf.2010.09.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Bacterial Agents--administration & dosage<br/>Ceftazidime--administration & dosage<br/>Cystic Fibrosis--complications<br/>Disease Progression<br/>Drug Administration Schedule<br/>Drug Monitoring<br/>Drug Therapy, Combination<br/>Ear Diseases--chemically induced<br/>Female<br/>Humans<br/>Injections, Intravenous<br/>Kidney Diseases--chemically induced<br/>Lung--microbiology<br/>Male<br/>Pseudomonas Infections--drug therapy<br/>Pseudomonas aeruginosa--drug effects<br/>Respiratory Function Tests<br/>Tobramycin--administration & dosage<br/>Treatment Outcome